Comparison of Different Bone Cement Formulations Containing Boron Derivatives
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2025
DOI: 10.1002/jbm.b.35640 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2025. Verfasst von Didem Aksu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Bone Cements, Materials Testing, Anti-Bacterial Agents, Polymethyl Methacrylate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
PMMA bone cement is mainly utilized to stabilize prosthetic implants; however, it is impacted by a variety of obstacles, including a lack of biocompatibility, limited thermal stability, a greater tendency to infection, and restricted mechanical strength. This study incorporates three different boron derivatives, boric acid, borax pentahydrate, and borax decahydrate into the polymethylmethacrylate (PMMA) bone cement formulation, leveraging their antibacterial properties to address the identified challenges. All three bone cement formulations were evaluated using scanning electron microscopy (SEM), Fourier‐transform infrared spectroscopy (FT‐IR), differential scanning calorimetry (DSC), and mechanical analysis. In addition, three formulations of bone cement were evaluated for cellular viability, antibacterial properties, and biocompatibility via a hemolysis assay. Borax decahydrate significantly influenced the biomechanical properties (214.32 MPa) of bone cement samples by decreasing the development of surface porosity in the materials. Borax pentahydrate demonstrated a greater beneficial effect than borax decahydrate in the majority of analyses; nevertheless, the most optimal results were achieved with boric acid. In the 3% boric acid bone cement samples, the cellular viability was significantly enhanced until 14 days as a consequence of the formation of porous structures. Moreover, these bone cement samples exhibited promising antibacterial characteristics and biocompatibility compared to commercial bone cement, both unmodified and antibiotic‐incorporated, demonstrating potential features for further research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Türkiye.
- Department of Orthopedics, Traumatology, Yeditepe University Hospitals, Istanbul, Türkiye.
ORCID-Profile: Gökhan Meriç, Gamze Torun Köse
Zitieren
APA
Aksu, D., Büyük, N. İ., Aksu, B. Ç., Meriç, G., & Köse, G. T. (2025). Comparison of Different Bone Cement Formulations Containing Boron Derivatives. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35640
Vancouver
Aksu D, Büyük Nİ, Aksu BÇ, Meriç G, Köse GT. Comparison of Different Bone Cement Formulations Containing Boron Derivatives. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2025. doi:10.1002/jbm.b.35640
BibTeX
@article{Aksu2025,
author = {Aksu, Didem and Büyük, Nisa İrem and Aksu, Burak Çağrı and Meriç, Gökhan and Köse, Gamze Torun},
title = {Comparison of Different Bone Cement Formulations Containing Boron Derivatives},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2025},
doi = {10.1002/jbm.b.35640}
}
EUVIMED